Regular biography
Catherine Kopecky is a researcher with a strong focus on the interplay between the renin-angiotensin system (RAS) and various diseases, including diabetes, kidney disease, and cancer. Her work spans multiple disciplines, including molecular biology, immunology, and biomedical engineering. She has contributed significantly to understanding how the RAS is regulated in different physiological and pathological contexts, particularly in the context of sodium-glucose cotransporter 2 (SGLT2) inhibition and angiotensin-converting enzyme (ACE) inhibition. Her research has also explored the role of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma and the development of patient-derived tumor models for precision medicine. Kopecky has published extensively in high-impact journals such as *Diabetologia*, *Circulation Research*, *Cancer Research*, and *Scientific Reports*. Her work has been supported by various grants and has led to important insights into the mechanisms underlying chronic diseases and potential therapeutic strategies.